T&R Biofab Co Ltd is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production and sale of three Dimensions (3D) biodegradable polymer printing system, bioinks, 3D organoid and 3D cell therapies, among others. The bioinks are sold under the name of deCelluid. The Company distributes its products within the domestic market and to overseas markets.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
04/08/26	₩2,795.00	+3.33%	422,869
03/08/26	₩2,705.00	-9.83%	1,720,387
31/07/26	₩3,000.00	+10.70%	777,576
30/07/26	₩2,710.00	+7.33%	719,566
29/07/26	₩2,525.00	+7.22%	946,117

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

End-of-day quote Korea S.E. Other stock markets 04/08/2026			5-day change	1st Jan Change
2,795.00 ^KRW	+3.33%		+13.16%	-28.52%

01-21	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
22/09/24	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI

Market Cap	133B 93.36M 81.06M 75.58M 69.43M 131M 8.88B 133M 891M 348M 4.44B 351M 343M 14.71B	P/E 2024	-12.2x	P/E 2025	-3.58x
Enterprise Value	155B 109M 94.27M 87.89M 80.74M 153M 10.33B 154M 1.04B 405M 5.16B 408M 399M 17.11B	EV / Sales 2024	25.1x	EV / Sales 2025	7.45x
Free-Float	78.94%	Yield 2024 *	-	Yield 2025	-

01-21	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
22/09/24	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI
04/08/24	T&R Biofab Co., Ltd. announced that it has received KRW 7 billion in funding from BTC Investment	CI
22/07/24	T&R Biofab Co., Ltd. announced that it expects to receive KRW 7 billion in funding from BTC Investment and another investor	CI
03/07/24	T&R Biofab Co., Ltd. announced that it has received KRW 2.99999656 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
24/06/24	T&R Biofab Co., Ltd. announced that it expects to receive KRW 2.9999956 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
21/12/23	T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
13/12/23	T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
18/10/23	CJ Foods Partners with T&R Biofab to Shape the Future of Food	CI
03/08/23	T&R Biofab Co., Ltd. announced that it has received KRW 24 billion in funding	CI
25/07/23	T&R Biofab Co., Ltd. announced that it expects to receive KRW 24 billion in funding	CI
15/05/23	T&R Biofab Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
20/09/21	T&R Biofab Co., Ltd.(KOSDAQ:A246710) added to S&P Global BMI Index	CI

1 day	+3.33%
1 week	+13.16%
Current month	-6.83%
1 month	+19.44%
3 months	-5.57%
6 months	-18.16%
Current year	-28.52%

T&R Biofab Co., Ltd. Share Price

Stocks

A246710

KR7246710008

Medical Equipment, Supplies & Distribution

Valuation: T&R Biofab Co., Ltd.

Chart: T&R Biofab Co., Ltd.

Latest news : T&R Biofab Co., Ltd.

Quotes and Performance

Course Extremes

Managers and Directors: T&R Biofab Co., Ltd.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	2,355	3,265
1 month	1,877	3,265
Current year	1,777	4,800
1 year	1,127	4,925
3 years	1,127	11,575
5 years	1,127	37,916.67
10 years	1,127	37,916.67

Manager	Title	Age	Since
Won-Soo Yoon CEO	Chief Executive Officer	56	-
Young-Pil Kim DFI	Director of Finance/CFO	53	-
Ju-Sung Sim COO	Chief Operating Officer	57	-

Director	Title	Age	Since
Won-Soo Yoon BRD	Director/Board Member	56	-
Jin-Hyung Shin BRD	Director/Board Member	41	-
Song-Wan Jin BRD	Director/Board Member	51	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
06/03/25	Marinho Paulo Andre Nobrega	Others		3,392	0.0157%
06/03/25	Eun-kyung Cho	Others		15,492	0.0719%
26/02/25	Won-Soo Yoon	Buy	Chief Executive Officer	2,100	0.0097%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
T&R BIOFAB CO., LTD.	+3.33%	+13.16%	-13.89%	-72.28%	90.06M
STRYKER CORPORATION	-1.54%	-3.07%	-11.93%	+18.42%	131B
SMITH & NEPHEW PLC	-6.27%	-3.44%	-2.98%	-0.18%	13.52B
GLAUKOS CORPORATION	-0.20%	+12.69%	+94.89%	+129.15%	10.07B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-0.94%	+0.47%	-43.13%	-67.12%	4.73B
DOUBLE MEDICAL TECHNOLOGY INC.	+1.17%	-2.77%	-3.31%	+34.58%	2.58B
ENOVIS CORPORATION	-1.78%	+4.54%	+15.88%	-47.90%	1.81B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-1.51%	+2.99%	-24.63%	-30.57%	1.71B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-0.47%	+3.47%	-14.80%	-17.83%	1.68B
Average	-0.91%	+4.22%	-0.43%	-5.97%	18.56B
Weighted average by Cap.	-1.77%	+2.15%	-5.38%	+19.79%

	2024	2025
Net sales	4.87B 3.42M 2.97M 2.77M 2.54M 4.8M 325M 4.86M 32.6M 12.74M 162M 12.83M 12.54M 538M	26.97B 18.9M 16.41M 15.3M 14.05M 26.58M 1.8B 26.87M 180M 70.51M 899M 70.97M 69.41M 2.98B
Net income	-7.68B -5.38M -4.67M -4.36M -4M -7.57M -512M -7.65M -51.36M -20.08M -256M -20.21M -19.76M -848M	-34.94B -24.49M -21.26M -19.83M -18.21M -34.44M -2.33B -34.82M -234M -91.37M -1.16B -91.96M -89.94M -3.86B
Net Debt	28.78B 20.17M 17.51M 16.33M 15M 28.37M 1.92B 28.68M 193M 75.25M 959M 75.74M 74.08M 3.18B	21.7B 15.21M 13.21M 12.31M 11.31M 21.39M 1.45B 21.63M 145M 56.74M 723M 57.11M 55.86M 2.4B